NCT07736482 Relationship Between Single- and Dual-Task Obstacle Crossing Performance and Fatigue and Disability in Multiple Sclerosis
| NCT ID | NCT07736482 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Afyonkarahisar Health Sciences University |
| Condition | Multiple Sclerosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 30 participants |
| Start Date | 2026-03-20 |
| Primary Completion | 2026-07-25 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30 participants in total. It began in 2026-03-20 with a primary completion date of 2026-07-25.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This cross-sectional observational study aims to investigate the relationship between obstacle crossing performance under single-task and dual-task conditions and the levels of fatigue and disability in individuals with Relapsing-Remitting Multiple Sclerosis (RRMS). Walking performance will be assessed under standard walking and obstacle crossing conditions with and without a concurrent cognitive task. The study will examine how increased task complexity affects walking performance and its association with fatigue, disability, cognition, and functional mobility.
Eligibility Criteria
Inclusion Criteria: * Age between 18 and 65 years. * Diagnosis of Multiple Sclerosis according to the 2017 McDonald criteria. * Diagnosis of Relapsing-Remitting Multiple Sclerosis. * Expanded Disability Status Scale (EDSS) score between 0 and 6. * Clinically stable disease during the previous 6 months. * Montreal Cognitive Assessment (MoCA) score of 26 or higher. * Able to speak and understand Turkish. * Able to provide written informed consent. Exclusion Criteria: * Multiple sclerosis relapse within the previous month. * Physician-diagnosed psychiatric disorder. * Neurological, orthopedic, cardiac, or pulmonary disease other than Multiple Sclerosis that could interfere with study assessments. * Montreal Cognitive Assessment (MoCA) score below 26.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07736482 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Multiple Sclerosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07736482 currently recruiting?
Yes, NCT07736482 is actively recruiting participants. Contact the research team at y.emre.kndkc@gmail.com for enrollment information.
Where is the NCT07736482 trial being conducted?
This trial is being conducted at Afyonkarahisar, Turkey (Türkiye).
Who is sponsoring the NCT07736482 clinical trial?
NCT07736482 is sponsored by Afyonkarahisar Health Sciences University. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.